NanJing Pharmaceutical Company Limited (SHA:600713)
China · Delayed Price · Currency is CNY 5.06
+0.02 (0.40%)
Sep 17, 2025, 2:45 PM CST
SHA:600713 Revenue
NanJing Pharmaceutical Company had revenue of 13.98B CNY in the quarter ending June 30, 2025, with 5.30% growth. This brings the company's revenue in the last twelve months to 54.43B, up 1.78% year-over-year. In the year 2024, NanJing Pharmaceutical Company had annual revenue of 53.70B with 0.20% growth.
Revenue (ttm)
54.43B
Revenue Growth
+1.78%
P/S Ratio
0.12
Revenue / Employee
11.27M
Employees
4,830
Market Cap
6.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 53.70B | 106.51M | 0.20% |
| Dec 31, 2023 | 53.59B | 3.37B | 6.71% |
| Dec 31, 2022 | 50.22B | 5.10B | 11.30% |
| Dec 31, 2021 | 45.12B | 5.31B | 13.33% |
| Dec 31, 2020 | 39.82B | 2.66B | 7.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 30.15B |
| WuXi AppTec | 41.90B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Sichuan Biokin Pharmaceutical | 441.19M |
| Shanghai United Imaging Healthcare | 10.98B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
| Aier Eye Hospital Group | 21.94B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |